Versatis now recommended for nerve pain in Scotland
This article was originally published in Scrip
The Scottish Medicines Consortiumhas decided to recommend Grünenthal's 5% lidocaine medicated plaster Versatis for restricted use within the Scottish NHS after all; it did not accept the product the first time round in February 2007, a month after it was approved in the UK.
You may also be interested in...
Cerimon Pharmaceuticals' once-daily topical-patch formulation of the NSAID diclofenac gave significantly better average pain relief than placebo in ankle-sprain patients who carried out their daily activities in a Phase II trial, at the third day in the study.
Following a second resubmission, the Scottish Medicines Consortiumhas accepted Lilly's Alimta (pemetrexed) for restricted use within the Scottish NHS as a monotherapy for the second-line treatment of locally advanced or metastatic non-small cell lung cancer.